 |
|
Home | Investment Analysts’ Weekly Ratings Changes for Trivascular Technologies (TRIV) |
 |
Investment Analysts’ Weekly Ratings Changes for Trivascular Technologies (TRIV)
|
 |
- May 14, 2015
-
Several analysts have recently updated their ratings and price targets for Trivascular Technologies (NASDAQ: TRIV): 5/8/2015 – Trivascular Technologies was downgraded by analysts at Zacks from a “buy” rating to a “sell” rating. Zacks’ analyst wrote, “Trivascular Technologies, Inc. is a medical device company. It is developing and commercializing technologies to significantly advance minimally invasive […]This article (Investment Analysts’ Weekly Ratings Changes for Trivascular Technologies (TRIV)) was originally developed by and is property of American Banking News.
Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
- Read more at:http://www.americanbankingnews.com/2015/05/14/investment-analysts-weekly-ratings-changes-for-trivascular-technologies-triv/
|
 |
|
 |
|
 |
